NORTH CHICAGO, Ill.,
Sept. 6, 2019 /PRNewswire/
-- The board of directors of AbbVie Inc. (NYSE: ABBV) declared
a quarterly cash dividend of $1.07
per share.
The cash dividend is payable November 15,
2019 to stockholders of record at the close of business on
October 15, 2019.
Since the company's inception in 2013, AbbVie has increased its
dividend by 168 percent. AbbVie is a member of the S&P
Dividend Aristocrats Index, which tracks companies that have
annually increased their dividend for at least 25 consecutive
years.
About AbbVie
AbbVie is a global, research and development-based
biopharmaceutical company committed to developing innovative
advanced therapies for some of the world's most complex and
critical conditions. The company's mission is to use its expertise,
dedicated people and unique approach to innovation to markedly
improve treatments across four primary therapeutic areas:
immunology, oncology, virology and neuroscience. In more than
75 countries, AbbVie employees are working every day to advance
health solutions for people around the world. For more information
about AbbVie, please visit us at www.abbvie.com. Follow
@abbvie on Twitter, Facebook,
LinkedIn or Instagram.
View original
content:http://www.prnewswire.com/news-releases/abbvie-declares-quarterly-dividend-300913243.html
SOURCE AbbVie